NNNN
NASDAQ · Biotechnology
Anbio Biotechnology Ltd
$3.89
+0.30 (+8.36%)
Performance
1D
+0.00%
1W
+10.83%
1M
-15.80%
3M
-61.83%
6M
-84.65%
1Y
-77.25%
YTD
-86.80%
Open$3.64
Previous Close$3.59
Day High$4.08
Day Low$3.51
52W High$44.73
52W Low$3.09
Volume—
Avg Volume34.4K
Market Cap516.57M
P/E Ratio50.64
EPS$0.23
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$5.07
Below
SMA 200
$16.62
Below
RSI (14)
65.3
Neutral
Trend
Death Cross
Bearish
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 26.29M | 36.72M | 1.84B |
| Net Income | 19.47M | 24.47M | -354,337,532 |
| Profit Margin | 74.1% | 70.4% | -19.2% |
| EBITDA | 17.54M | 23.27M | -454,323,212 |
| Free Cash Flow | — | — | -249,462,362 |
| Rev Growth | -28.4% | -28.4% | +17.6% |
| Debt/Equity | — | — | 0.51 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |